On the public citation graph

Broad-Spectrum Cyclopropane-Based Inhibitors of Coronavirus 3C-like Proteases: Biochemical, Structural, and Virological Studies

0 signed · 87 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/anie.202016961openalex-snapshot
Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors
inferredcites →https://doi.org/10.1002/cmdc.202100456openalex-snapshot
MPI8 is Potent against SARS‐CoV‐2 by Inhibiting Dually and Selectively the SARS‐CoV‐2 Main Protease and the Host Cathepsin L**
inferredcites →https://doi.org/10.1002/cmdc.202200440openalex-snapshot
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19
inferredcites →https://doi.org/10.1016/j.bbrc.2012.08.015openalex-snapshot
Reprint of “On the Size of the Active Site in Proteases. I. Papain”
inferredcites →https://doi.org/10.1016/j.bmcl.2012.11.026openalex-snapshot
Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors
inferredcites →https://doi.org/10.1016/j.celrep.2020.108254openalex-snapshot
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
inferredcites →https://doi.org/10.1016/j.coviro.2021.06.008openalex-snapshot
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2
inferredcites →https://doi.org/10.1016/j.ijantimicag.2020.106054openalex-snapshot
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies
inferredcites →https://doi.org/10.1016/j.ijantimicag.2020.106055openalex-snapshot
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
inferredcites →https://doi.org/10.1016/s0040-4039(00)78856-3openalex-snapshot
N,N`-dissuccinimidyl carbonate: a useful reagent for alkoxycarbonylation of amines
inferredcites →https://doi.org/10.1016/s0140-6736(21)00370-6openalex-snapshot
SARS-CoV-2 variants and ending the COVID-19 pandemic
inferredcites →https://doi.org/10.1021/acs.jmedchem.0c00606openalex-snapshot
COVID-19: Drug Targets and Potential Treatments
inferredcites →https://doi.org/10.1021/acs.jmedchem.0c01140openalex-snapshot
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
inferredcites →https://doi.org/10.1021/acs.jmedchem.0c02258openalex-snapshot
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00319openalex-snapshot
Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00335openalex-snapshot
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00409openalex-snapshot
Perspectives on SARS-CoV-2 Main Protease Inhibitors
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00509openalex-snapshot
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00598openalex-snapshot
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL pro )
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00616openalex-snapshot
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00628openalex-snapshot
Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00665openalex-snapshot
3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c01037openalex-snapshot
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c01214openalex-snapshot
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure–Activity Relationship, and X-ray Structural Studies
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c01494openalex-snapshot
Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c00224openalex-snapshot
Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c01005openalex-snapshot
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b00472openalex-snapshot
The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b00497openalex-snapshot
Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease
inferredcites →https://doi.org/10.1021/jacs.2c04626openalex-snapshot
Dual Inhibitors of Main Protease (M Pro ) and Cathepsin L as Potent Antivirals against SARS-CoV2
inferredcites →https://doi.org/10.1021/jo990543vopenalex-snapshot
A Novel, Nonaqueous Method for Regeneration of Aldehydes from Bisulfite Adducts
inferredcites →https://doi.org/10.1021/ml3000963openalex-snapshot
Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS
inferredcites →https://doi.org/10.1038/nsb0497-269openalex-snapshot
Improved R-factors for diffraction data analysis in macromolecular crystallography
inferredcites →https://doi.org/10.1038/s41392-021-00558-8openalex-snapshot
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development
inferredcites →https://doi.org/10.1038/s41467-020-16256-yopenalex-snapshot
A human monoclonal antibody blocking SARS-CoV-2 infection
inferredcites →https://doi.org/10.1038/s41467-021-26239-2openalex-snapshot
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
inferredcites →https://doi.org/10.1038/s41467-022-32854-4openalex-snapshot
X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation
inferredcites →https://doi.org/10.1038/s41586-020-2008-3openalex-snapshot
A new coronavirus associated with human respiratory disease in China
inferredcites →https://doi.org/10.1038/s41586-020-2223-yopenalex-snapshot
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
inferredcites →https://doi.org/10.1038/s41586-022-04474-xopenalex-snapshot
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
inferredcites →https://doi.org/10.1055/s-0029-1218754openalex-snapshot
Sodium Bromodifluoroacetate: A Difluorocarbene Source for the Synthesis of gem-Difluorocyclopropanes
inferredcites →https://doi.org/10.1056/nejmc2100362openalex-snapshot
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
inferredcites →https://doi.org/10.1073/pnas.0505577102openalex-snapshot
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
inferredcites →https://doi.org/10.1073/pnas.2003138117openalex-snapshot
Cell entry mechanisms of SARS-CoV-2
inferredcites →https://doi.org/10.1073/pnas.2025866118openalex-snapshot
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
inferredcites →https://doi.org/10.1073/pnas.2101555118openalex-snapshot
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
inferredcites →https://doi.org/10.1073/pnas.2117142119openalex-snapshot
Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2
inferredcites →https://doi.org/10.1101/2022.02.09.479835openalex-snapshot
Dual Inhibition of Cathepsin L and 3CL-Pro by GC-376 Constrains SARS Cov2 Infection Including Omicron Variant
inferredcites →https://doi.org/10.1107/s0021889800018227openalex-snapshot
Global indicators of X-ray data quality
inferredcites →https://doi.org/10.1107/s0021889807021206openalex-snapshot
Phaser crystallographic software
inferredcites →https://doi.org/10.1107/s0021889887009737openalex-snapshot
Automatic indexing of rotation diffraction patterns
inferredcites →https://doi.org/10.1107/s0907444904023716openalex-snapshot
Developments in theCCP4 molecular-graphics project
inferredcites →https://doi.org/10.1107/s0907444905036693openalex-snapshot
Scaling and assessment of data quality
inferredcites →https://doi.org/10.1107/s0907444909042073openalex-snapshot
MolProbity : all-atom structure validation for macromolecular crystallography
inferredcites →https://doi.org/10.1107/s0907444909047337openalex-snapshot
XDS
inferredcites →https://doi.org/10.1107/s0907444909052925openalex-snapshot
PHENIX : a comprehensive Python-based system for macromolecular structure solution
inferredcites →https://doi.org/10.1107/s0907444910007493openalex-snapshot
Features and development of Coot
inferredcites →https://doi.org/10.1107/s090744491003982xopenalex-snapshot
An introduction to data reduction: space-group determination, scaling and intensity statistics
inferredcites →https://doi.org/10.1107/s0907444911007773openalex-snapshot
Data processing and analysis with the autoPROC toolbox
inferredcites →https://doi.org/10.1126/sciadv.abe0751openalex-snapshot
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L
inferredcites →https://doi.org/10.1126/science.1218231openalex-snapshot
Linking Crystallographic Model and Data Quality
inferredcites →https://doi.org/10.1126/science.1222162openalex-snapshot
Resolving Some Old Problems in Protein Crystallography
inferredcites →https://doi.org/10.1126/science.abb3405openalex-snapshot
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
inferredcites →https://doi.org/10.1126/science.abb4489openalex-snapshot
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
inferredcites →https://doi.org/10.1126/science.abf1611openalex-snapshot
SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model
inferredcites →https://doi.org/10.1126/science.abl4784openalex-snapshot
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
inferredcites →https://doi.org/10.1126/scitranslmed.abc5332openalex-snapshot
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice
inferredcites →https://doi.org/10.1128/jvi.01348-12openalex-snapshot
Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
inferredcites →https://doi.org/10.1128/spectrum.01789-21openalex-snapshot
Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
inferredcites →https://doi.org/10.1177/1098612x17729626openalex-snapshot
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis
inferredcites →https://doi.org/10.1371/journal.ppat.1005531openalex-snapshot
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
inferredcites →https://doi.org/10.15252/embj.2021107821openalex-snapshot
TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
inferredcites →https://doi.org/10.26508/lsa.202000786openalex-snapshot
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
inferredcites →https://doi.org/10.3390/jcm9061885openalex-snapshot
Vaccines and Therapies in Development for SARS-CoV-2 Infections
inferredcites →https://doi.org/10.3390/molecules27082523openalex-snapshot
Advances in the Development of SARS-CoV-2 Mpro Inhibitors

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115376openalex-snapshot
Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115772openalex-snapshot
Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116704openalex-snapshot
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
inferred← citeshttps://doi.org/10.1016/j.sbi.2023.102667openalex-snapshot
Structural biology of SARS-CoV-2 Mpro and drug discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00551openalex-snapshot
Structure-Guided Design of Potent Coronavirus Inhibitors with a 2-Pyrrolidone Scaffold: Biochemical, Crystallographic, and Virological Studies
inferred← citeshttps://doi.org/10.1021/acsptsci.3c00313openalex-snapshot
Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity
inferred← citeshttps://doi.org/10.1039/d3md00493gopenalex-snapshot
On the origins of SARS-CoV-2 main protease inhibitors
inferred← citeshttps://doi.org/10.1128/mbio.02878-23openalex-snapshot
Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment
inferred← citeshttps://doi.org/10.1128/spectrum.03372-23openalex-snapshot
Potent small molecule inhibitors against the 3C protease of foot-and-mouth disease virus
inferred← citeshttps://doi.org/10.1186/s12917-025-04822-9openalex-snapshot
Host susceptibilities and entry processes of SARS-CoV-2 Omicron variants using pseudotyped viruses carrying spike protein
inferred← citeshttps://doi.org/10.26434/chemrxiv-2023-lfxqv-v2openalex-snapshot
Main Proteases of Key RNA Viruses, Including Coronavirus, Recognize P2 Residues in the Polyproline Type II Conformation: Harnessing Proline's Unique Conformation for Protease Inhibitors
inferred← citeshttps://doi.org/10.3390/ijms26041481openalex-snapshot
Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.